Success Metrics

Clinical Success Rate
85.2%

Based on 190 completed trials

Completion Rate
85%(190/223)
Active Trials
25(8%)
Results Posted
46%(88 trials)
Terminated
33(10%)

Phase Distribution

Ph phase_1
29
9%
Ph phase_4
78
24%
Ph not_applicable
56
18%
Ph early_phase_1
4
1%
Ph phase_2
62
19%
Ph phase_3
76
24%

Phase Distribution

33

Early Stage

62

Mid Stage

154

Late Stage

Phase Distribution305 total trials
Early Phase 1First-in-human
4(1.3%)
Phase 1Safety & dosage
29(9.5%)
Phase 2Efficacy & side effects
62(20.3%)
Phase 3Large-scale testing
76(24.9%)
Phase 4Post-market surveillance
78(25.6%)
N/ANon-phased studies
56(18.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

78.8%

190 of 241 finished

Non-Completion Rate

21.2%

51 ended early

Currently Active

25

trials recruiting

Total Trials

319

all time

Status Distribution
Active(33)
Completed(190)
Terminated(51)
Other(45)

Detailed Status

Completed190
unknown41
Terminated33
Withdrawn18
Recruiting18
Not yet recruiting8

Development Timeline

Analytics

Development Status

Total Trials
319
Active
25
Success Rate
85.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (1.3%)
Phase 129 (9.5%)
Phase 262 (20.3%)
Phase 376 (24.9%)
Phase 478 (25.6%)
N/A56 (18.4%)

Trials by Status

completed19060%
withdrawn186%
active_not_recruiting72%
recruiting186%
terminated3310%
not_yet_recruiting83%
suspended41%
unknown4113%

Recent Activity

Clinical Trials (319)

Showing 20 of 319 trialsScroll for more
NCT07608328Phase 4

Azithromycin to Modify Bronchiectasis Exacerbation Risk

Recruiting
NCT07164131Phase 4

Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams

Recruiting
NCT06082037Phase 3

A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction

Recruiting
NCT05121974Phase 2

Tebipenem Trial in Children With Shigellosis

Completed
NCT00322465Phase 2

NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole)

Completed
NCT06349122Phase 3

AUTOP 2: Screen-and-treat Strategy for Vaginal Flora Abnormalities by Molecular Biology in Pregnant Women at High Risk of Preterm Birth

Not Yet Recruiting
NCT05994742Phase 3

An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM

Completed
NCT07777952Not Applicable

Adjunctive 308-nm Excimer Light With Oral Azithromycin for Inflammatory Acne

Completed
NCT04069312Phase 3

Roflumilast or Azithromycin to Prevent COPD Exacerbations Trial

Completed
NCT07780292Phase 4

Effect of Post Operative Low Dose Oral Azithromycin in Chronic Rhinosinusitis Patients With Nasal Polyps

Not Yet Recruiting
NCT06223828Phase 2

Azithromycin for Critical Asthma - Pediatrics

Recruiting
NCT04326478Phase 2

Single Dose Azithromycin to Prevent Cholera in Children

Completed
NCT04224987Phase 4

Azithromycin for Child Survival in Niger: Mortality and Resistance Trial

Completed
NCT00980148Phase 3

Treatment Failure of Chlamydial Infection in Males and Females in Youth Correctional Facilities

Completed
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT07713186Phase 4

Azithromycin in Atopic Dermatitis

Not Yet Recruiting
NCT04287049Phase 2

A Study of Standard Drugs for Mycobacterium Avium Complex

Completed
NCT04669288Phase 3

AZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency Department

Terminated
NCT05922761Phase 2

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

Recruiting
NCT06273891Phase 3

Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes

Active Not Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
319